Heterocyclic Compounds: News and Research on Pyrimidines

MeSH tree: D03.383.742

PCSK9, statin combo may cut cholesterol post-transplant

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation ...

page 2 from 21